WebApr 28, 2024 · ESPR Esperion Therapeutics Inc Esperion Announces the Appointment of Stephen Rocamboli to its Board of Directors ANN ARBOR, Mich., April 28, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Stephen Rocamboli as a Class I director, with a term expiring at the 2024 annual meeti... WebApr 28, 2024 · ANN ARBOR, Mich., April 28, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced the appointment of Stephen Rocamboli as a Class I director, with a term expiring at the 2024 annual ...
Management Team - Xyphos Biosciences, Inc.
WebThe Dedham Group. Nov 2014 - Dec 20162 years 2 months. Greater New York City Area. The Dedham Group, is a boutique healthcare innovation company offering strategy consulting services for the life ... WebApr 14, 2024 · Abstract. High-risk neuroblastoma (NB) has a poor prognosis despite multimodal treatment. To improve survival and minimise treatment side-effects, research has focused on developing more effective therapeutic strategies. Anaplastic lymphoma kinase (ALK) is a promising druggable target as its expression rapidly decreases in … budgetary planning techniques
Board of Directors Esperion Therapeutics, Inc.
WebFunctional. Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Analytics. Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the ... WebMr. Rocamboli is currently Chief Executive Officer of Perla Therapeutics, Inc., a company located in the greater Boston area, developing first-in-class antibody therapeutics for the treatment of cancer. Previously, he served as Chief Business Officer, General Counsel and Corporate Secretary of Candel Therapeutics, an immuno-oncology company ... WebAssociate Director, Business Development at BlueRock Therapeutics . Perla Corredor is an Associate Director, Business Development at BlueRock Therapeutics based in Cambridge, Massachusetts. Read More . Contact. Perla Corredor's Phone Number and Email Last Update. 4/8/2024 7:03 PM. Email. cricketholic